Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AYTU BIOPHARMA, INCFinancial_Report.xls
10-Q - AYTU BIOPHARMA, INCrosewind10q2282015.htm
EX-31 - AYTU BIOPHARMA, INCex31_1.htm

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

The undersigned, James B. Wiegand, Chief Executive Officer of Rosewind Corporation (the “Company”), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Quarterly Report on Form 10-Q of the Company for the quarter ended February 28, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

/s/ James B. Wiegand

James B. Wiegand

Principal Executive Officer and Principal Financial Officer

April 15, 2015